ATE247476T1 - Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure - Google Patents

Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure

Info

Publication number
ATE247476T1
ATE247476T1 AT96901681T AT96901681T ATE247476T1 AT E247476 T1 ATE247476 T1 AT E247476T1 AT 96901681 T AT96901681 T AT 96901681T AT 96901681 T AT96901681 T AT 96901681T AT E247476 T1 ATE247476 T1 AT E247476T1
Authority
AT
Austria
Prior art keywords
hyaluronic acid
blidder
inflammation
treating interstitial
interstitial cystitis
Prior art date
Application number
AT96901681T
Other languages
German (de)
English (en)
Inventor
Alvaro Morales
Stanley J Alkemade
Original Assignee
Bioniche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/388,038 external-priority patent/US5591724A/en
Application filed by Bioniche Inc filed Critical Bioniche Inc
Application granted granted Critical
Publication of ATE247476T1 publication Critical patent/ATE247476T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)
AT96901681T 1995-02-14 1996-02-14 Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure ATE247476T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/388,038 US5591724A (en) 1995-02-14 1995-02-14 Method for treating the urinary bladder and associated structures using hyaluronic acid
US59101596A 1996-02-08 1996-02-08
PCT/CA1996/000094 WO1996025168A1 (en) 1995-02-14 1996-02-14 Use of hyaluronic acid for the treatment of interstitial cystitis

Publications (1)

Publication Number Publication Date
ATE247476T1 true ATE247476T1 (de) 2003-09-15

Family

ID=27012116

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96901681T ATE247476T1 (de) 1995-02-14 1996-02-14 Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure

Country Status (20)

Country Link
US (1) US5888986A (en, 2012)
EP (1) EP0813417B1 (en, 2012)
JP (1) JP4354528B2 (en, 2012)
KR (1) KR100268660B1 (en, 2012)
CN (1) CN1181016A (en, 2012)
AT (1) ATE247476T1 (en, 2012)
AU (1) AU705289B2 (en, 2012)
BR (1) BR9607601A (en, 2012)
CA (1) CA2203621C (en, 2012)
CZ (1) CZ288218B6 (en, 2012)
DE (1) DE69629553T2 (en, 2012)
DK (1) DK0813417T3 (en, 2012)
ES (1) ES2205013T3 (en, 2012)
HU (1) HUP9800467A3 (en, 2012)
IN (1) IN181358B (en, 2012)
NO (1) NO315842B1 (en, 2012)
NZ (1) NZ300903A (en, 2012)
PT (1) PT813417E (en, 2012)
TR (1) TR199700782T1 (en, 2012)
WO (1) WO1996025168A1 (en, 2012)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739601B2 (en) * 1991-07-03 2001-10-18 Meditech Research Limited Use of hyaluronan in gene therapy
US6548487B2 (en) 1996-12-27 2003-04-15 Seikagaku Corporation Agent for treatment of bladder troubles
EP0891775A4 (en) * 1996-12-27 2002-07-24 Seikagaku Kogyo Co Ltd MEDICINE FOR URBAN BLADDER DISORDERS
ATE264674T1 (de) 1998-10-22 2004-05-15 Bioniche Life Sciences Inc Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
PT1238070E (pt) * 1999-12-13 2007-11-06 Bioniche Life Sciences Inc Oligonucleótidos sintéticos úteis sob o ponto de vista terapêutico
JP4215429B2 (ja) * 1999-12-28 2009-01-28 バイオニケ ライフ サイエンシーズ インコーポレイテッド 癌治療におけるヒアルロン酸
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
RU2270678C1 (ru) * 2004-06-30 2006-02-27 Государственное образовательное учреждение высшего профессионального образования Российский государственный медицинский университет Министерства здравоохранения Российской Федерации Способ лечения хронического цистита у детей
KR20070121644A (ko) * 2005-01-14 2007-12-27 유리젠, 인코포레이티드 하부 요로 치료용 키트 및 개선된 조성물
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
EP2545925B1 (en) 2011-07-12 2018-02-14 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
ITMI20111732A1 (it) * 2011-09-27 2013-03-28 Bsdpharma Srl Formulazioni farmaceutiche per la riduzione della sensibilizzazione crociata tra colon-retto ed il distretto urogenitale con mezzi non-farmacologici.
RU2519010C1 (ru) * 2013-03-20 2014-06-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Композиция для лечения цистита
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
CN103655601B (zh) * 2013-12-31 2019-10-25 上海建华精细生物制品有限公司 一种用于膀胱灌洗的组合物
CN103861091B (zh) * 2014-03-20 2016-04-27 辽宁亿灵科创生物医药科技有限公司 治疗膀胱炎的药物组合物
US20160045623A1 (en) 2015-04-03 2016-02-18 Lipella Pharmaceuticals, Inc. Systems and Methods to Image Intercellular and Intercompartmental Defects with Magnetic Resonance Imaging (MRI)
WO2015154007A1 (en) * 2014-04-03 2015-10-08 Lipella Pharmaceuticals, Inc. Systems and methods of detecting interstitial cystitis
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
GB201616838D0 (en) * 2016-10-04 2016-11-16 Nat Univ Ireland Hyaluronan compositions, and uses thereof in treatment of interstitial cystitis
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
IT201900019762A1 (it) * 2019-10-24 2021-04-24 Fidia Farm Spa Composizione farmaceutica per uso nel trattamento della cistite di varia eziologia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4296104A (en) * 1979-08-30 1981-10-20 Herschler R J Therapeutic dimethyl sulfoxide composition and methods of use
US4302577A (en) * 1979-10-05 1981-11-24 Biomed Research Inc. Process for preparing CSA or CSC
US5180715A (en) * 1980-11-17 1993-01-19 The Regents Of The University Of California Irrigation of internal bladder surfaces in mammals with sodium pentosanpolysulfate
DE3118588C2 (de) * 1981-05-11 1983-07-07 Luitpold-Werk, Chemisch-Pharmazeutische Fabrik, 8000 München Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung
US4640912A (en) * 1983-06-09 1987-02-03 Hausman Marvin S Administration of "active" chondroitin sulfate A and "active" chondroitin sulfate C or mixtures thereof to mammals including humans
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
ES2150427T3 (es) * 1992-06-02 2000-12-01 Bard Inc C R Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
CA2158638C (en) * 1993-03-19 1999-11-30 Bengt Agerup A composition and a method for tissue augmentation

Also Published As

Publication number Publication date
IN181358B (en, 2012) 1998-05-30
WO1996025168A1 (en) 1996-08-22
NO973732D0 (no) 1997-08-13
NZ300903A (en) 1999-07-29
HUP9800467A2 (hu) 1998-06-29
CZ257497A3 (cs) 1998-01-14
BR9607601A (pt) 1999-09-14
DE69629553T2 (de) 2004-06-17
AU4617996A (en) 1996-09-04
MX9706182A (es) 1998-07-31
KR19980702251A (ko) 1998-07-15
ES2205013T3 (es) 2004-05-01
JPH10513476A (ja) 1998-12-22
JP4354528B2 (ja) 2009-10-28
EP0813417B1 (en) 2003-08-20
DE69629553D1 (de) 2003-09-25
TR199700782T1 (xx) 1998-03-21
HUP9800467A3 (en) 1999-01-28
NO973732L (no) 1997-10-10
CN1181016A (zh) 1998-05-06
CA2203621C (en) 1998-04-28
PT813417E (pt) 2003-12-31
CA2203621A1 (en) 1996-08-22
NO315842B1 (no) 2003-11-03
KR100268660B1 (ko) 2000-10-16
EP0813417A1 (en) 1997-12-29
AU705289B2 (en) 1999-05-20
CZ288218B6 (en) 2001-05-16
DK0813417T3 (da) 2003-11-03
US5888986A (en) 1999-03-30

Similar Documents

Publication Publication Date Title
ATE247476T1 (de) Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
ZA988278B (en) Ionic polymers as toxin-binding agents
IL123500A (en) Composite biomaterials for preventing post-surgical adhesions of tissues
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
BR9714385A (pt) Método para tratamento e prevenção de deficiência cardìaca e dilatação ventricular
MY113490A (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
ATE193443T1 (de) Verwendung eines imidazols zur herstellung eines medikamentes zur behandlung der arteriosklerose
PT755265E (pt) Combinacao de hormona do crescimento e factor de crescimento semelhante a insulina para tratamento da insuficiencia cardiaca congestiva
DE69027220D1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ATE248592T1 (de) Verwendung von naaladase hemmern zur herstellung eines medikaments zur behandlung von bestimmten krankheiten
DE69721747D1 (de) Methode zur behandlung oder verhütung von interstitieller blasenentzundung
ATE264674T1 (de) Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
EP1150698A4 (en) USE OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING ERECTILE DYSFUNCTIONS
FI962549A0 (fi) Metallinen siirrännäinen ja menetelmä metallisen siirrännäisen käsittelemiseksi
EP1007093A4 (en) TREATMENT METHODS OF INTERLEUKIN-9 DISORDERS AND THEIR ANTAGONISTS
NZ505294A (en) Use of fat-binding polymers in combination with one or more lipase inhibitors to treat obesity and hypertriglyceridemia and for reducing the absorption of dietary fat in mammals, and the use of fat-binding polymers to treat steatorrhea
DE69835210D1 (de) Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
DE69428120D1 (de) Lokal anwendbares präparat zur reepithelisierung bei andauernden epitheldefekten
RU97115451A (ru) Способ лечения интерстициального цистита
BG98035A (en) Method for decreasing the disintegration of concrete, caused by freezing and defreezing
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
ATE291431T1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0813417

Country of ref document: EP

EEIH Change in the person of patent owner